Mechanisms of EGF receptor regulation in breast cancer cells

Overexpression of the EGF receptor in breast cancer correlates with poor prognosis and failure on endocrine therapy for both ER−/EGFR+ and ER+/EGFR+ tumors, suggesting a role for EGFR in the progression to hormone independence. The identification of specific DNase I hypersensitive site patterns for the EGFR gene in ER+ vs. ER− cells implicates regions of the EGFR first intron in up-regulation of EGFR, while estrogen regulation studies indicate the involvement of a repressor(s) in the maintenance of low levels of EGFR. Based on these findings, a multi-step model is proposed for the progression of breast cancer from a hormone-dependent, ER+/EGFR- phenotype to an aggressive, hormone-independent, ER−/EGFR+ stage.

[1]  P. Hamilton,et al.  Modulation of transforming growth factor alpha‐dependent expression of epidermal growth factor receptor gene by transforming growth factor beta, triiodothyronine, and retinoic acid , 1989, Journal of cellular biochemistry.

[2]  P. Hamilton,et al.  Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor beta 1, and triiodothyronine in MDA-468 cells. , 1989, The Journal of biological chemistry.

[3]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[4]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER , 1985 .

[5]  J. Foekens,et al.  Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. , 1992, Cancer research.

[6]  M. Kraus,et al.  A novel human gene closely related to the abl proto-oncogene. , 1986, Science.

[7]  M. Rosner,et al.  Regulation of epidermal growth factor receptor gene expression by retinoic acid and epidermal growth factor. , 1989, The Journal of biological chemistry.

[8]  I. Pastan,et al.  Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs. , 1985, Nucleic acids research.

[9]  R. Dickson,et al.  Breast cancer: influence of endocrine hormones, growth factors and genetic alterations. , 1993, Advances in experimental medicine and biology.

[10]  S. Chrysogelos.  Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells. , 1993, Nucleic acids research.

[11]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[13]  G. Merlo,et al.  Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA , 1989, Molecular carcinogenesis.

[14]  S. Bates,et al.  Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.

[15]  R. Dickson,et al.  Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. , 1986, Science.

[16]  J. B. Santon,et al.  Regulation of epidermal growth factor receptor gene expression. , 1989, Molecular endocrinology.

[17]  B. Angus,et al.  Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. , 1988, British Journal of Cancer.

[18]  B. Roe,et al.  Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  I. Pastan,et al.  A transcription factor active on the epidermal growth factor receptor gene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Field,et al.  Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. , 1983, Cancer research.

[21]  L. Goldsmith,et al.  Transcriptional control of epidermal growth factor receptor by retinoic acid. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  R. Shoemaker,et al.  A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. , 1988, Molecular endocrinology.

[23]  W. Gullick,et al.  Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. , 1991, British medical bulletin.

[24]  E. Gelmann,et al.  Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. , 1987, Molecular endocrinology.

[25]  G. Merlo,et al.  Stromal influences on transformation of human mammary epithelial cells overexpressing c‐myc and SV40T , 1990, Journal of cellular physiology.

[26]  I. Pastan,et al.  Epidermal growth factor (EGF) receptor gene transcription , 1988 .

[27]  G. Stein,et al.  Native genomic blotting: high-resolution mapping of DNase I-hypersensitive sites and protein-DNA interactions. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Chiew,et al.  Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. , 1992, The Journal of biological chemistry.

[29]  M A Lazar,et al.  Thyroid hormone decreases the expression of epidermal growth factor receptor. , 1991, The Journal of biological chemistry.

[30]  I. Pastan,et al.  Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites. , 1988, The Journal of biological chemistry.

[31]  J. Wittliff,et al.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. , 1984, Cancer research.

[32]  I. Pastan,et al.  Cooperative function of two separate enhancers of the human epidermal growth factor receptor proto-oncogene. , 1989, The Journal of biological chemistry.

[33]  D. Goeddel,et al.  Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation , 1986, Cell.

[34]  J. Farndon,et al.  EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER , 1989, The Lancet.

[35]  L. Hudson,et al.  Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y H Xu,et al.  Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  I. Pastan,et al.  Molecular cloning and characterization of a human DNA binding factor that represses transcription , 1989, Cell.

[38]  T. Fleming,et al.  Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. , 1989, Oncogene.

[39]  R. Dickson,et al.  Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. , 1991, The Journal of biological chemistry.

[40]  J. E. Kudlow,et al.  Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. Evidence for a common mechanism. , 1987, The Journal of biological chemistry.

[41]  D. S. Gross,et al.  Nuclease hypersensitive sites in chromatin. , 1988, Annual review of biochemistry.

[42]  I. Pastan,et al.  Epidermal growth factor regulates the expression of its own receptor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Waterfield,et al.  Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis. , 1991, The Journal of biological chemistry.

[44]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.

[45]  V. Mukku,et al.  Regulation of epidermal growth factor receptor by estrogen. , 1985, The Journal of biological chemistry.

[46]  G. Stancel,et al.  Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. , 1988, Molecular endocrinology.

[47]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[48]  M. Kraus,et al.  Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms. , 1987, The EMBO journal.

[49]  V. Mukku.  Regulation of epidermal growth factor receptor levels by thyroid hormone. , 1984, The Journal of biological chemistry.

[50]  J. Garcia-conde,et al.  Epidermal growth factor receptor in human breast cancer: correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristics. , 1990, European journal of cancer.

[51]  J. Farndon,et al.  Synthetic oligonucleotides as therapeutic agents. , 1991, British Journal of Cancer.

[52]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[53]  M N Pollak,et al.  MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. , 1985, Biochemical and biophysical research communications.

[54]  J. Bjorge,et al.  Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line. , 1986, The Journal of biological chemistry.

[55]  Michael Chinkers,et al.  A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. , 1982, The Journal of biological chemistry.

[56]  J. B. Santon,et al.  Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression , 1990, Cell.

[57]  S. Bates,et al.  Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. , 1989, Molecular endocrinology.